Aktiesnakken — Juli 2010
-
det er faktisk uhyggeligt
-
det er nok svært at se royalty overstiger 700 mill før 2013
-
man skal dog ikke glemme at neurosearch i mange år har "levet" af at udlicensiere stoffer tidligere
-
ja selvom det er forbudt
-
-
læg mærke til omsætningen idag
-
hvis den fortsætter kan genmab ikke holdes nede
-
Hebi what?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind